Changes over 13 years in skin reactivity to histamine in cohorts of children aged 9-13 years

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 5, 2001, Pages 436-441

  Ronchetti, Roberto ^a   Villa, M Pia ^a   Ciofetta, G ^a   Barreto, M ^a   Falasca, C ^a   Martella, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Children; Epidemiology; Histamine skin reactivity; Histamine wheals

Indexed keywords

HISTAMINE;

ADOLESCENT; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; SKIN MANIFESTATION; SKIN SENSITIZATION; URTICARIA;

ADOLESCENT; AGE DISTRIBUTION; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH SURVEYS; HISTAMINE; HUMANS; HYPERSENSITIVITY; INTRADERMAL TESTS; MALE; OBSERVER VARIATION; PREVALENCE; ROME; TIME FACTORS;

EID: 0034997592     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.056005436.x     Document Type: Article

References (35)

1. Sibbald B, Rink E, D'Souza M. Is the prevalence of atopy increasing? Br J Gen Pract 1990;40:338-340.
2. Nakagomi T, Itaya H, Tominaga T, Yamaki M, Hisamatsu S, Nakagomi O. Is atopy increasing? Lancet 1994;343:121-122.
3. Von Mutius E, Weiland SK, Fritzsech C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998;351:862-866.
4. Ronchetti R, Bonci E, Macri F, Antognoni G, Indinnimeo L, Tancredi G. Increase of allergen skin test positivity and of bronchial reactivity in children: 9-year prevalence trend. Riv Ital Pediatr 1998;24:294-299.
5. Riikjarv MA, Julge K, Vasar M, Braback L, Knutsson A, Bjǒrksten B. The prevalence of atopic sensitization and respiratory symptoms among Estonian schoolchildren. Clin Exp Allergy 1995;25:1198-1204.
6. Martinez FD, Antognoni G, Macri F, Bonci E, Midulla F, De Castro G. Parental smoking enhances bronchial responsiveness in nine year old children. Am Rev Respir Dis 1988;138:518-523.
7. Ronchetti R, Bonci E, Cutrera R, De Castro G, Indinnimeo L, Midulla F. Enhanced allergic sensitisation related to parental smoking. Arch Dis Child 1992;67:496-500.
8. Ronchetti R, Macri F, Ciofetta G, Indinnimeo L, Cutrera R, Bonci E. Increased serum IgE and increased prevalence of eosinophilia in 9-year-old children of smoking parents. J Allergy Clin Immunol 1990;86:400-407.
9. Pepys J. Skin testing. Br J Hosp Med 1975;14:412-417.
10. Nelson HS, Rosloniec DM, McCall LI, Iklè D. Comparative performance of five commercial prick skin test devices. J Allergy Clin Immunol 1993;92:750-756.
11. Nelson HS, Lahr J, Buchmeier A, McCormick D. Clinical aspects of allergic disease. Evaluation of devices for skin prick testing. J Allergy Clin Immunol 1998;101:153-156.
12. Niemeijer NR, Goedewaagen B, Kauffman HF, De Monchy JGR. Optimization of skin testing. I. Choosing allergen concentrations and cutoff values by factorial design. Allergy 1993;48:491-497.
13. Demoly P, Bousquet J, Manderscheid JC, Dreborg S, Dhivert H, Michel FB, Precision skin prick and puncture tests with nine methods. J Allergy Clin Immunol 1991;88:758-762.
14. Dreborg S, Holgersson M, Nilsson G, Zetterstrǒm O. Dose response relationship of allergen, histamine and histamine releasers, skin prick test and precision of the skin prick test method. Allergy 1987;42:117-125.
15. Taudorf E, Malling H-J, Laursen LC, Lanner A, Weeke B. Reproducibility of histamine skin prick test. Allergy 1985;40:344-349.
16. Van Neste D. Skin response to histamine. Acta Derm Venereol 1991;71:25-28.
17. Menardo JL, Bousquet J, Rodière M, Astruc J, Michel FB. Skin test reactivity in infancy. J Allergy Clin Immunol 1985;75:646-651.
18. Skassa-Brociek W, Manderscheid JC, Michel FB, Bousquet J. Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol 1987;80:711-716.
19. Malling H-J. Skin prick testing and the use of histamine references. Allergy 1984;39:596-601.
20. Barbee RA, Brown WG, Kaltenborn W, Halonen M. Allergen skin-test reactivity in a community population sample: correlation with age, histamine skin reactions, and total serum immunoglobulin E. J Allergy Clin Immunol 1981;68:15-19.
21. Dreborg S. Skin tests used in type I allergy testing. Position paper. Prepared by the Subcommittee on Skin Tests of the EAACI. Allergy 1989;44 Suppl 10:11-15.
22. Malling H-J. Quantitative skin prick testing. Allergy 1987;42:196-204.
23. Van Asperen PP, Kemp AS, Mellis CM. Skin test reactivity and clinical allergen sensitivity in infancy. J Allergy Clin Immunol 1984;73:381-386.
24. Strachan DP. Lifestyle and atopy. Lancet 1999;353:1457-1458.
25. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999;353:1485-1488.
26. Bjǒrksten B. Risk factors for sensitization and development of allergic diseases. In: Blumental MN, Björkstén B, editors. Genetics of allergy and asthma.
27. Lewis T. The blood vessels of the human skin and their responses. London: Shaw, 1927.
28. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Goodman LS, Gilman A, Rall TW, Murad F, editors. The pharmacological basis of therapeutics. New York: Macmillan, 1985:605-638.
29. 4 and role in allergic leucocyte recruitment. Clin Exp Allergy 1997;27:445-451.
30. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide. Eur J Pharmacol 1985;114:61-66.
31. Kaplan AP, Kuna P, Reddigari SR. Chemokines as allergic mediators - relationship to histamine-releasing factors. Allergy 1994;49:495-501.
32. Columbo M, Horowitz EM, Botana LM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Allergy Clin Immunol 1992;149:599-608.
33. Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994;7:1161-1171.
34. Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM. Substance P activates the release of histamine from human skin mast cells through a pertussis toxin-sensitive and protein kinase C-dependent mechanism. Clin Immunol Immunopathol 1996;81:68-73.
35. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatic and nonasthmatics. Eur Respir J 1991;4:673-682.